1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Left Ventricular Assist Device (LVAD)
  • 1.3.3 Biventricular Assist Device (BiVAD)
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Bridge-to-transplant (BTT)
  • 1.4.3 Destination Therapy (DT)
  • 1.4.4 Others
• 1.5 Global Fully MagLev Ventricular Assist Device (VAD) Market Size & Forecast
  • 1.5.1 Global Fully MagLev Ventricular Assist Device (VAD) Consumption Value (2020 & 2024 & 2031)
  • 1.5.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Quantity (2020-2031)
  • 1.5.3 Global Fully MagLev Ventricular Assist Device (VAD) Average Price (2020-2031)

2 Manufacturers Profiles

• 2.1 Abbott
  • 2.1.1 Abbott Details
  • 2.1.2 Abbott Major Business
  • 2.1.3 Abbott Fully MagLev Ventricular Assist Device (VAD) Product and Services
  • 2.1.4 Abbott Fully MagLev Ventricular Assist Device (VAD) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Abbott Recent Developments/Updates
• 2.2 BiVACOR
  • 2.2.1 BiVACOR Details
  • 2.2.2 BiVACOR Major Business
  • 2.2.3 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Product and Services
  • 2.2.4 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 BiVACOR Recent Developments/Updates
• 2.3 Suzhou Tongxin Medical Devices
  • 2.3.1 Suzhou Tongxin Medical Devices Details
  • 2.3.2 Suzhou Tongxin Medical Devices Major Business
  • 2.3.3 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Product and Services
  • 2.3.4 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Suzhou Tongxin Medical Devices Recent Developments/Updates
• 2.4 Shenzhen Core Medical Technology
  • 2.4.1 Shenzhen Core Medical Technology Details
  • 2.4.2 Shenzhen Core Medical Technology Major Business
  • 2.4.3 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Product and Services
  • 2.4.4 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Shenzhen Core Medical Technology Recent Developments/Updates

3 Competitive Environment: Fully MagLev Ventricular Assist Device (VAD) by Manufacturer

• 3.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Manufacturer (2020-2025)
• 3.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Manufacturer (2020-2025)
• 3.3 Global Fully MagLev Ventricular Assist Device (VAD) Average Price by Manufacturer (2020-2025)
• 3.4 Market Share Analysis (2024)
  • 3.4.1 Producer Shipments of Fully MagLev Ventricular Assist Device (VAD) by Manufacturer Revenue ($MM) and Market Share (%): 2024
  • 3.4.2 Top 3 Fully MagLev Ventricular Assist Device (VAD) Manufacturer Market Share in 2024
  • 3.4.3 Top 6 Fully MagLev Ventricular Assist Device (VAD) Manufacturer Market Share in 2024
• 3.5 Fully MagLev Ventricular Assist Device (VAD) Market: Overall Company Footprint Analysis
  • 3.5.1 Fully MagLev Ventricular Assist Device (VAD) Market: Region Footprint
  • 3.5.2 Fully MagLev Ventricular Assist Device (VAD) Market: Company Product Type Footprint
  • 3.5.3 Fully MagLev Ventricular Assist Device (VAD) Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Size by Region
  • 4.1.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Region (2020-2031)
  • 4.1.2 Global Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Region (2020-2031)
  • 4.1.3 Global Fully MagLev Ventricular Assist Device (VAD) Average Price by Region (2020-2031)
• 4.2 North America Fully MagLev Ventricular Assist Device (VAD) Consumption Value (2020-2031)
• 4.3 Europe Fully MagLev Ventricular Assist Device (VAD) Consumption Value (2020-2031)
• 4.4 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Consumption Value (2020-2031)
• 4.5 South America Fully MagLev Ventricular Assist Device (VAD) Consumption Value (2020-2031)
• 4.6 Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Consumption Value (2020-2031)

5 Market Segment by Type

• 5.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Type (2020-2031)
• 5.2 Global Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Type (2020-2031)
• 5.3 Global Fully MagLev Ventricular Assist Device (VAD) Average Price by Type (2020-2031)

6 Market Segment by Application

• 6.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Application (2020-2031)
• 6.2 Global Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Application (2020-2031)
• 6.3 Global Fully MagLev Ventricular Assist Device (VAD) Average Price by Application (2020-2031)

7 North America

• 7.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Type (2020-2031)
• 7.2 North America Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Application (2020-2031)
• 7.3 North America Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
  • 7.3.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Country (2020-2031)
  • 7.3.2 North America Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Country (2020-2031)
  • 7.3.3 United States Market Size and Forecast (2020-2031)
  • 7.3.4 Canada Market Size and Forecast (2020-2031)
  • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

• 8.1 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Type (2020-2031)
• 8.2 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Application (2020-2031)
• 8.3 Europe Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
  • 8.3.1 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Country (2020-2031)
  • 8.3.2 Europe Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Country (2020-2031)
  • 8.3.3 Germany Market Size and Forecast (2020-2031)
  • 8.3.4 France Market Size and Forecast (2020-2031)
  • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
  • 8.3.6 Russia Market Size and Forecast (2020-2031)
  • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

• 9.1 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Type (2020-2031)
• 9.2 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Application (2020-2031)
• 9.3 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Market Size by Region
  • 9.3.1 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Region (2020-2031)
  • 9.3.2 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Region (2020-2031)
  • 9.3.3 China Market Size and Forecast (2020-2031)
  • 9.3.4 Japan Market Size and Forecast (2020-2031)
  • 9.3.5 South Korea Market Size and Forecast (2020-2031)
  • 9.3.6 India Market Size and Forecast (2020-2031)
  • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
  • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

• 10.1 South America Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Type (2020-2031)
• 10.2 South America Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Application (2020-2031)
• 10.3 South America Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
  • 10.3.1 South America Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Country (2020-2031)
  • 10.3.2 South America Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Country (2020-2031)
  • 10.3.3 Brazil Market Size and Forecast (2020-2031)
  • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

• 11.1 Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Type (2020-2031)
• 11.2 Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Application (2020-2031)
• 11.3 Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
  • 11.3.1 Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Sales Quantity by Country (2020-2031)
  • 11.3.2 Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Consumption Value by Country (2020-2031)
  • 11.3.3 Turkey Market Size and Forecast (2020-2031)
  • 11.3.4 Egypt Market Size and Forecast (2020-2031)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
  • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

• 12.1 Fully MagLev Ventricular Assist Device (VAD) Market Drivers
• 12.2 Fully MagLev Ventricular Assist Device (VAD) Market Restraints
• 12.3 Fully MagLev Ventricular Assist Device (VAD) Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Fully MagLev Ventricular Assist Device (VAD) and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Fully MagLev Ventricular Assist Device (VAD)
• 13.3 Fully MagLev Ventricular Assist Device (VAD) Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Fully MagLev Ventricular Assist Device (VAD) Typical Distributors
• 14.3 Fully MagLev Ventricular Assist Device (VAD) Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Fully MagLev Ventricular Assist Device (VAD) market size was valued at US$ 1167 million in 2024 and is forecast to a readjusted size of USD 2514 million by 2031 with a CAGR of 11.7% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. The fully magnetic levitation VAD uses a fully magnetically levitated centrifugal pump, which has the advantages of small size, strong biocompatibility, and good infection risk prevention and control.
Currently, the global fully magnetic levitation ventricular assist device (VAD) market is monopolized by Abbott's HeartMate 3, which has now become the most commonly used left ventricular assist device (LVAD) in the world, with a market share of over 80%.
From the perspective of the global VAD device market, the main manufacturer in the United States is Abbott, and full magnetic levitation products have become the absolute mainstream. Competition in Europe is more intense, with more products approved earlier, but they are mainly used the second-generation technology (axial pump). The main player is Berlin heart CmbH.
This report is a detailed and comprehensive analysis for global Fully MagLev Ventricular Assist Device (VAD) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fully MagLev Ventricular Assist Device (VAD) market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Fully MagLev Ventricular Assist Device (VAD) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Fully MagLev Ventricular Assist Device (VAD) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Fully MagLev Ventricular Assist Device (VAD) market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fully MagLev Ventricular Assist Device (VAD)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fully MagLev Ventricular Assist Device (VAD) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BiVACOR, Suzhou Tongxin Medical Devices, Shenzhen Core Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Fully MagLev Ventricular Assist Device (VAD) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Left Ventricular Assist Device (LVAD)
Biventricular Assist Device (BiVAD)
Market segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Others
Major players covered
Abbott
BiVACOR
Suzhou Tongxin Medical Devices
Shenzhen Core Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fully MagLev Ventricular Assist Device (VAD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fully MagLev Ventricular Assist Device (VAD), with price, sales quantity, revenue, and global market share of Fully MagLev Ventricular Assist Device (VAD) from 2020 to 2025.
Chapter 3, the Fully MagLev Ventricular Assist Device (VAD) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fully MagLev Ventricular Assist Device (VAD) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Fully MagLev Ventricular Assist Device (VAD) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fully MagLev Ventricular Assist Device (VAD).
Chapter 14 and 15, to describe Fully MagLev Ventricular Assist Device (VAD) sales channel, distributors, customers, research findings and conclusion.